back to US directory
us clinical guidance

Perinatal mental-health screening and treatment

ACOG-aligned universal screening with care systems, bipolar assessment, individualized treatment and emergency postpartum escalation.

JurisdictionUnited States
Source check2026-08-20
Clinical reviewiatroX editorial team · Clinical editorial review · reviewed 2026-08-20 · due 2027-08-20
AudienceUnited States healthcare professionals caring for pregnant and postpartum people
This is an iatroX educational summary of named United States sources, not an official guideline. It does not replace the complete source documents, local policy, specialist advice or clinical judgement. Use the named authority, current FDA labeling, applicable state law, payer rules and local protocol where relevant.

Scope of this summary

People receiving well-woman, prepregnancy, prenatal or postpartum care, including conditions that predate pregnancy or arise through the first postpartum year. ACOG Clinical Practice Guidelines 4 and 5 cover depression, anxiety, bipolar disorder, suicidality and acute psychosis.
sources for this section:ACOG CPG 4ACOG CPG 5

The Bottom Line

  • Screen for depression and anxiety with validated instruments at the initial prenatal visit, later in pregnancy and postpartum, within a system that can assess, treat and monitor positive results.
  • Screen for bipolar disorder before starting pharmacotherapy for depression or anxiety when it has not already been assessed, because treatment strategy and risk can differ materially.
  • Do not withhold or discontinue psychiatric medication solely because of pregnancy or lactation; compare risks of treatment, untreated illness, relapse and alternatives through shared decision-making.
  • Obstetric clinicians should be prepared to initiate appropriate treatment, refer to behavioral-health care or both and use a validated measure to monitor response and remission.
sources for this section:ACOG CPG 4ACOG CPG 5

Practical clinical workflow

1
At each planned screen, review the result promptly and ask about function, sleep beyond infant-related disruption, anxiety, intrusive thoughts, mania, psychosis, trauma, substances, supports and infant or dependent safety.
2
For a positive screen, complete diagnostic and suicide-risk assessment, review prior episodes and medicines and coordinate obstetric, primary-care, psychiatric and pediatric or lactation expertise as needed.
3
Select psychotherapy, pharmacotherapy or combined care based on diagnosis, severity, prior response, gestational or postpartum stage, feeding plan, medical factors, access and patient values.
4
Arrange an explicit follow-up interval, monitor symptoms with the same instrument, adjust toward remission when clinically indicated and ensure handoff when routine postpartum care ends.
sources for this section:ACOG CPG 4ACOG CPG 5

Safety boundaries and escalation

  • An affirmative self-harm or suicide response requires immediate assessment of likelihood, acuity and severity and a risk-tailored disposition; do not defer review until a later obstetric appointment.
  • Postpartum psychosis is a psychiatric emergency requiring immediate medical attention, protection of the patient and infant and specialist treatment.
  • Mania, severe agitation, inability to sleep for reasons beyond infant care, delusions, hallucinations, confusion or thoughts of harming the infant requires urgent same-day assessment.
  • Avoid abrupt medication discontinuation and avoid simplistic claims that a medicine is completely safe or unsafe; use the live label, current ACOG focused updates and individual reproductive context.
sources for this section:ACOG CPG 4ACOG CPG 5VA/DoD suicide risk 2024

Localization

Use the current ACOG clinical practice guidelines and focused updates alongside current FDA labeling. State perinatal psychiatry access programs, Medicaid extension, crisis systems and reproductive law vary.
sources for this section:ACOG CPG 4ACOG CPG 5

Source documents

Use the linked source documents for complete recommendations, evidence grading, exclusions and implementation detail.

  1. American College of Obstetricians and Gynecologists Committee on Clinical Practice Guidelines—ObstetricsScreening and Diagnosis of Mental Health Conditions During Pregnancy and PostpartumACOG Clinical Practice Guideline No. 4; Obstet Gynecol. 2023;141:1232–1261 · published 2023-06-01 · accessed 2026-08-20
    view source
  2. American College of Obstetricians and Gynecologists Committee on Clinical Practice Guidelines—ObstetricsTreatment and Management of Mental Health Conditions During Pregnancy and PostpartumACOG Clinical Practice Guideline No. 5; Obstet Gynecol. 2023;141:1262–1288 · published 2023-06-01 · accessed 2026-08-20
    view source
  3. U.S. Department of Veterans Affairs and U.S. Department of Defense Evidence-Based Practice Work GroupVA/DoD Clinical Practice Guideline for Assessment and Management of Patients at Risk for Suicide2024 guideline; official guideline page checked 2026-08-20 · accessed 2026-08-20
    view source
continue the learning

From guidance to deliberate practice and evidence

Choose what happens next. iatroX can carry this page's jurisdiction, source-check date and released version into an editable learning record, support your reflection, or let you browse the regional question bank while keeping this topic visible. No action records completion, starts a session or awards CPD/CME credit automatically.

Add this guidance review to CPD/CMEOpen an editable learning-log record with this page’s provenance attached. You confirm the activity, time, reflection and mappings.Reflect on this with TutorUse optional prompts to consider what you learned and what—if anything—you may change. Suggestions are never inserted automatically.Browse the US question bankKeep this guidance topic in view, then choose your exam and filters. No session starts automatically.
Found a source update or regional discrepancy? Tell the iatroX editorial team.